IMGN853-0420 -Multicenter, open-label, phase 2 study of carboplatin soravtansine followed by mirvetuximab soravtansine c folate receptor-alpha positive, recurrent platinum-sens epithelial ovarian, primary peritoneal, or fallopian tub 1 prior line of plat

Project: Research project

Project Details

StatusActive
Effective start/end date1/9/23 → 1/9/26

Funding

  • Ergomed Clinical Research Ltd. (IMGN853 // IMGN853-0420)
  • ImmunoGen, Inc. (IMGN853 // IMGN853-0420)